Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anika Therapeutics

14.08
-0.4100-2.83%
Post-market: 14.080.00000.00%16:01 EDT
Volume:76.42K
Turnover:1.09M
Market Cap:201.93M
PE:-3.68
High:14.72
Open:14.30
Low:13.91
Close:14.49
Loading ...
Feb 26, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 09, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 09, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 22, 2024

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Jan 20, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 03, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 03, 2023

Major Issues Report

Form 8-K - Current report
Sep 21, 2023

Major Issues Report

Form 8-K - Current report
Sep 11, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Aug 17, 2023

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership
Aug 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2023

Major Issues Report

Form 8-K - Current report
Aug 08, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jun 21, 2023

Major Issues Report

Form 8-K - Current report
May 09, 2023

Major Issues Report

8-K - Current report
May 09, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 28, 2023

Major Issues Report

8-K - Current report
Apr 13, 2023

Major Issues Report

8-K - Current report
Apr 05, 2023

Correspondence

Form CORRESP - Correspondence